Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

United Therapeutics (UTHR) Insider Trading & Ownership

$353.00
+1.67 (+0.48%)
(As of 09/20/2024 ET)

United Therapeutics (NASDAQ:UTHR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.50%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
8
Amount Of
Insider Selling
(Last 12 Months)
$95.66 M
Get UTHR Insider Trade Alerts

Want to know when executives and insiders are buying or selling United Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

UTHR Insider Buying and Selling by Quarter

United Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/9/2024James EdgemondCFOSell7,802$345.41$2,694,888.82  
9/3/2024James EdgemondCFOSell7,785$362.37$2,821,050.45  
8/26/2024Martine A RothblattCEOSell269$348.41$93,722.29  
8/19/2024Martine A RothblattCEOSell3,600$344.18$1,239,048.00  
8/8/2024Martine A RothblattCEOSell3,600$328.39$1,182,204.00  
8/7/2024Michael BenkowitzCOOSell25,000$323.38$8,084,500.00  
Ex-Wall Street CEO reveals “Millionaire-Maker” Superdrug (Ad)

Science Magazine called it the "breakthrough of the year"... With projections of 8,966% growth in the next four years.

Click here for our #1 "Retirement Window" Stock >>>
8/6/2024Martine A RothblattCEOSell3,600$325.45$1,171,620.00  
8/2/2024Martine A RothblattCEOSell3,600$324.73$1,169,028.00  
8/2/2024Raymond DwekDirectorSell5,000$325.35$1,626,750.00  
7/30/2024Martine A RothblattCEOSell3,600$337.40$1,214,640.00  
7/26/2024Martine A RothblattCEOSell3,600$338.61$1,218,996.00  
7/24/2024Martine A RothblattCEOSell3,600$334.00$1,202,400.00  
7/22/2024Martine A RothblattCEOSell3,600$331.32$1,192,752.00  
7/18/2024Martine A RothblattCEOSell3,600$331.79$1,194,444.00  
7/16/2024Martine A RothblattCEOSell3,600$328.03$1,180,908.00  
7/12/2024Martine A RothblattCEOSell3,600$324.97$1,169,892.00  
7/10/2024Martine A RothblattCEOSell3,600$326.35$1,174,860.00  
7/8/2024Martine A RothblattCEOSell3,600$317.05$1,141,380.00  
7/5/2024Martine A RothblattCEOSell3,600$313.25$1,127,700.00  
7/3/2024Martine A RothblattCEOSell3,600$312.48$1,124,928.00  
7/1/2024Martine A RothblattCEOSell3,600$320.45$1,153,620.00  
6/27/2024Martine A RothblattCEOSell3,600$316.62$1,139,832.00  
6/25/2024Nilda MesaDirectorSell266$318.58$84,742.28  
6/24/2024Martine A RothblattCEOSell3,600$315.97$1,137,492.00  
6/21/2024Martine A RothblattCEOSell3,600$313.91$1,130,076.00  
6/14/2024Martine A RothblattCEOSell3,600$287.22$1,033,992.00  
6/13/2024Christopher CauseyDirectorSell2,000$281.53$563,060.00  
6/12/2024Martine A RothblattCEOSell3,600$281.19$1,012,284.00  
6/10/2024Martine A RothblattCEOSell3,600$273.95$986,220.00  
6/7/2024Martine A RothblattCEOSell3,600$277.13$997,668.00  
5/31/2024Martine A RothblattCEOSell3,600$272.48$980,928.00  
5/28/2024Martine A RothblattDirectorSell3,600$269.06$968,616.00  
5/23/2024Martine A RothblattDirectorSell3,600$275.78$992,808.00  
5/21/2024Martine A RothblattDirectorSell1,468$275.85$404,947.80  
5/16/2024Martine A RothblattDirectorSell3,600$272.37$980,532.00  
5/14/2024Christopher PatuskyDirectorSell1,310$264.35$346,298.50  
5/13/2024Martine A RothblattCEOSell3,600$265.48$955,728.00  
5/9/2024Martine A RothblattCEOSell3,600$264.22$951,192.00  
5/6/2024Martine A RothblattCEOSell3,600$259.70$934,920.00  
5/3/2024Christopher CauseyDirectorSell2,240$259.91$582,198.40  
"Doomsday indicator” flashing for the first time since the Great Depression... (Ad)

It's been a bloodbath in the markets. The seven most valuable US tech companies lost a combined $1 trillion - in a single day. And things could get a lot worse...

Click here to discover how Wall Street insiders are quietly preparing for a market crash >>>
5/2/2024Martine A RothblattCEOSell3,600$258.09$929,124.00  
4/30/2024Martine A RothblattCEOSell3,600$235.35$847,260.00  
4/26/2024Martine A RothblattCEOSell3,600$235.20$846,720.00  
4/24/2024Martine A RothblattCEOSell3,600$238.81$859,716.00  
4/22/2024Martine A RothblattCEOSell3,600$236.47$851,292.00  
4/18/2024Martine A RothblattCEOSell3,600$237.91$856,476.00  
4/16/2024Martine A RothblattCEOSell3,600$232.05$835,380.00  
4/12/2024Martine A RothblattCEOSell3,600$235.42$847,512.00  
4/10/2024Martine A RothblattCEOSell13,800$237.27$3,274,326.00  
4/8/2024Martine A RothblattCEOSell5,060$237.52$1,201,851.20  
4/4/2024Martine A RothblattCEOSell15,000$233.27$3,499,050.00  
4/4/2024Paul A MahonEVPSell6,000$232.37$1,394,220.00  
3/28/2024Martine A RothblattCEOSell14,125$236.18$3,336,042.50  
3/27/2024Nilda MesaDirectorSell325$237.80$77,285.00  
3/26/2024Martine A RothblattCEOSell15,000$248.33$3,724,950.00  
3/22/2024Martine A RothblattCEOSell15,000$237.05$3,555,750.00  
3/21/2024Paul A MahonEVPSell6,000$236.45$1,418,700.00  
3/19/2024Martine A RothblattCEOSell15,000$236.59$3,548,850.00  
2/23/2024Christopher PatuskyDirectorSell1,680$224.00$376,320.00  
2/15/2024Paul A MahonEVPSell6,000$215.31$1,291,860.00  
2/1/2024Paul A MahonEVPSell6,000$215.01$1,290,060.00  
1/18/2024Paul A MahonEVPSell6,000$218.72$1,312,320.00  
1/4/2024Paul A MahonEVPSell6,000$227.97$1,367,820.00  
12/21/2023Paul A MahonEVPSell6,000$229.27$1,375,620.00  
12/19/2023Nilda MesaDirectorSell605$244.90$148,164.50  
12/12/2023Christopher CauseyDirectorSell3,000$249.68$749,040.00  
12/7/2023Paul A MahonEVPSell6,000$238.89$1,433,340.00  
11/2/2023Paul A MahonEVPSell6,000$225.76$1,354,560.00  
10/19/2023Paul A MahonEVPSell6,000$225.43$1,352,580.00  
10/5/2023Paul A MahonEVPSell6,000$223.82$1,342,920.00  
(Data available from 1/1/2013 forward)

UTHR Insider Trading Activity - Frequently Asked Questions

12.50% of United Therapeutics stock is owned by insiders. Learn more on UTHR's insider holdings.

The following insider purchased UTHR shares in the last 24 months: Christopher Patusky ($684.36).

Insiders have purchased a total of 6 UTHR shares in the last 24 months for a total of $684.36 bought.

The following insiders have sold UTHR shares in the last 24 months: Christopher Causey ($1,894,298.40), Christopher Patusky ($723,157.05), James Edgemond ($5,515,939.27), Judy D Olian ($284,820.00), Louis W Sullivan ($883,639.60), Martine A Rothblatt ($163,998,226.29), Michael Benkowitz ($8,084,500.00), Nilda Mesa ($732,972.40), Paul A Mahon ($42,575,115.00), and Raymond Dwek ($1,626,750.00).

Insiders have sold a total of 889,447 United Therapeutics shares in the last 24 months for a total of $226,319,418.01 sold.



This page (NASDAQ:UTHR) was last updated on 9/22/2024 by MarketBeat.com Staff
From Our Partners